About 30 results found for searched term "FAAH" (0.278 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M6169 | FAAH-IN-2 | FAAH |
| FAAH-IN-2 is a potent FAAH (fatty acid amide hydrolase) inhibitor. | ||
| M22340 | FAAH inhibitor 1 | Others |
| FAAH inhibitor 1 | ||
| M2783 | JNJ-1661010 | FAAH |
| Takeda-25 | ||
| JNJ-1661010 is a potent and selective FAAH inhibitor with IC50 of 10 nM (rat) and 12 nM (human), exhibits >100-fold selectivity for FAAH-1 when compared to FAAH-2. | ||
| M3404 | URB597 | FAAH |
| KDS-4103 | ||
| URB597 is a potent, orally bioavailable FAAH inhibitor with IC50 of 4.6 nM, with no activity on other cannabinoid-related targets. | ||
| M3525 | PF-3845 | FAAH |
| PF-3845 is a potent, selective and irreversible FAAH inhibitor with Ki of 230 nM, showing negligible activity against FAAH2. | ||
| M4693 | Biochanin-A | FAAH |
| 4-Methylgenistein; Olmelin | ||
| Biochanin A is A naturally occurring fatty acid amide hydrolase (FAAH) inhibitor that inhibits FAAH in mice, rats and humans with FAAH IC50 of 1.8, 1.4 and 2.4 μM, respectively. | ||
| M4890 | JZL 195 | MAGL |
| GTPL8606, KB-78011 | ||
| JZL195 is an effective FAAH and MAGL inhibitor with IC50 of 2 nM and 4 nM, respectively. | ||
| M6455 | Arachidonyl serotonin | TRP Channel |
| Arachidonyl serotonin is a dual FAAH inhibitor/TRPV1 antagonist. | ||
| M6462 | ARN272 | Others |
| ARN 272 | ||
| ARN272 is a fAAH-like anandamide transporter (FLAT) inhibitor. | ||
| M7011 | NADA | Others |
| NADA is a endogenous CB 1 agonist. Also vanilloid agonist and inhibitor of FAAH and AMT. | ||
| M7101 | Palmitoylisopropylamide | Others |
| Palmitoylisopropylamide is a inhibitor of FAAH. | ||
| M7115 | PF 04457845 | FAAH |
| PF 04457845 is a potent and selective irreversible FAAH inhibitor. | ||
| M7124 | PF 750 | Others |
| PF 750 is a selective FAAH inhibitor. | ||
| M7240 | SA 47 | Others |
| SA 47 is a selective FAAH inhibitor. | ||
| M7241 | SA 57 | Others |
| SA 57 is a potent FAAH inhibitor. | ||
| M7349 | TAK 21d | Others |
| TAK 21d is a potent FAAH inhibitor. | ||
| M7369 | TC-F 2 | Others |
| TC-F 2 is a potent, reversible and selective FAAH inhibitor. | ||
| M8346 | AZ513 | Others |
| AZ513 is a reversible, noncompetitive FAAH inhibitor. | ||
| M8377 | UCM710 | Others |
| UCM710 is a dual inhibitor of fatty acid amide hydrolase (FAAH) and α/β hydrolase domain 6 (ABHD6) the enzymes that hydrolyze endocannabinoids. | ||
| M8449 | PDP-EA | Others |
| 3-N-Pentadecylphenolethan |
||
| M8950 | JNJ-42165279 | FAAH |
| JNJ-42165279 is a potent and selective FAAH inhibitor with IC50s of 70 ± 8 nM and 313 ± 28 nM for hFAAH and rFAAH, respectively. | ||
| M9271 | BIA 10-2474 | FAAH |
| BIA10-2474 | ||
| BIA 10-2474 is a long-acting reversible inhibitor of fatty acid amide hydrolase (FAAH). | ||
| M13370 | KML-29 | MAGL |
| KML29 is an effective selective MAGL inhibitor with IC50 values of 15 nM, 43 nM and 5.9 nM in mice, rats and humans, respectively. KML29 has minimal cross-reaction with other central and peripheral serine hydrolases including FAAH. | ||
| M14425 | LY2183240 | FAAH |
| LY2183240 is a highly potent blocker of anandamide uptake (IC50= 270 pM; Ki=540 nM). LY2183240 is a potent, covalent inhibitor of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) with an IC50 of 12.4 nM. | ||
| M14426 | URB-597 | FAAH |
| KDS-4103 | ||
| URB-597 (KDS-4103) is an orally bioavailable and selective FAAH inhibitor. | ||
| M18241 | N-Benzylpalmitamide | FAAH |
| Macamide 1; Hexadecanamide, N-benzyl- | ||
| N-Benzylpalmitamide is a macamide isolated from Lepidium meyenii, acts as an inhibitor of fatty acid amide hydrolase (FAAH). | ||
| M27945 | MK-4409 | FAAH |
| MK-4409 is a potent oxazole FAAH inhibitor and can be used for the research of inflammatory and neuropathic pain. | ||
| M29986 | MAGL-IN-5 | MAGL |
| CAY10499 | ||
| MAGL-IN-5 (CAY10499) is a non-selective lipase inhibitor with IC50 values of 144, 90, and 14 nM for human recombinant monoacylglycerol lipase(MAGL),hormone sensitive lipase(HSL), and fatty acid amide hydrolase(FAAH) respectively. | ||
| M44941 | N-(3-Methoxybenzyl)palmitamide | FAAH |
| N-(3-Methoxybenzyl)Palmitamide is a promising inhibitor of FAAH for the treatment of pain, inflammation and CNS degenerative disorders. | ||
| M44945 | N-Benzyllinolenamide | FAAH |
| N-Benzyllinolenamide is a natural macamide isolated from Lepidium meyenii, acts as an inhibitor of fatty acid amide hydrolase (FAAH) with an IC50 of 41.8 μM. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
